Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Don2018on Nov 05, 2019 1:34pm

90 Views

Post# 30311367

RE:RE:Updates to watch out for - Sirona’s top 10

skiboard09 wrote: That is a very ambitious time frame. It would be amazing if the stock price could get there that quickly. But seems like we are stuck at .45 until we get some really good news

And anyone calling for a multi-dollar share price in 6 months is a blatant pumper.

SBM has lots going for it, but it will all take time.

$3 in 3 years I can imagine, if everything goes well, which would still be a HUGE return.

But $3 in 6 months? Pure bs.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week